Turnstone Biologics

Turnstone Biologics

  • Founded: 2015
  • Location: Ottawa, ON
  • Employee range: 50 - 200
  • Clinical stage: Clin1
  • Therapy area: Multiple cancers
  • Drug types: ONC
  • Lead product: TIDAL-01
  • Product link: https://turnstonebio.com/#pipeline
  • Funding: $80M IPO Jul 2023; $80M D Jul 2021; $41M B Nov 2016



job board

Short description:

Oncolytic viral immunotherapy

Drug notes:

Also Clin1 melanomas, combo Clin0 solid tumors; TIDAL-02 Clin0 solid tumors

Long description:

Contact us to add description.


© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com